InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,722.26
(
-0.19%
)
US TECH 100
19,518.00
(
0.53%
)
Dow Jones
41,914.75
(
-0.70%
)
Brent Oil
72.42
(
-1.06%
)
Bitcoin
63,461.46
(
0.52%
)
Post# of 97239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jockinmikeg

Send PM Follow Ignore
Followers 68
Posts 2653
Boards Moderated 0
Alias Born 08/20/2013

jockinmikeg

Re: None

Tuesday, 08/04/2015 9:23:06 AM

Tuesday, August 04, 2015 9:23:06 AM

Post# of 97239
$SNGX Soligenix Receives Orphan Drug Designation from the European Commission for SGX301 as a Treatment for Cutaneous T-Cell Lymphoma (CTCL)

http://www.prnewswire.com/news-releases/soligenix-receives-orphan-drug-designation-from-the-european-commission-for-sgx301-as-a-treatment-for-cutaneous-t-cell-lymphoma-300122212.html
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up